Blog

Revolutionary Proteins Transform Nutrient Monitoring in Biopharma
🔍 Researchers have developed a potential alternative technology for nutrient monitoring in biopharma using periplasmic binding proteins. 💡

Boost Efficiency: Ship Smart from the Start!
📢 Advanced therapy manufacturers must prioritize shipping logistics early on to optimize product transportation. Consult with World Courier and Pharmalex for expert guidance.

Revolutionizing Bioprocessing with Integrated Microfluidics
📝 Bioprocessing can benefit from the integration of microfluidic devices, similar to how integrated circuits transformed computing. 🌡️ Microfluidics offer advantages such as testing multiple variables quickly and using low reagent levels. 🧪 Researchers developed an integrated microfluidic device for continuous bioprocessing, allowing for the screening and optimization of multiple conditions. 🔬 The device demonstrated consistent production of green fluorescent protein (GFP) over eight days. ⏱️ Integrated microfluidic devices have the potential to revolutionize biomanufacturing with rapid screening and optimization capabilities.

Roche’s €90m Gene Therapy Hub Revolutionizes Research
Roche opens €90m gene therapy development centre in Germany 🏢🧬💉💊 to advance gene therapy research worldwide 🌍.

AstraZeneca Buys Fusion Therapeutics for $2 Billion Revolutionizing Cancer Treatment
🔬 AstraZeneca is acquiring Fusion Therapeutics Inc for $2 billion upfront to transform cancer treatment with targeted therapies. 💰🌟

Syngene’s India Biologics Facility Ready by Mid-Year
📢 Syngene International's new biologics manufacturing facility in India to be operational from mid-year. 💉🏭 Tripled capacity, expansion plans underway!

Unlocking Biosimilars: Affordable Medicines for Global Health
💉 Affordable access to key medicines as patents expire. 👩⚕️ Regulatory hurdles and defensive tactics hinder US growth. 👨🔬 QTL technology improves consistency. 💰 Lower costs for biosimilars. 🚀 Attractive investment opportunity.








